M&A Deal Summary

Pharmaron Acquires Biortus

On October 28, 2025, Pharmaron acquired life science company Biortus

Acquisition Highlights
  • This is Pharmaron’s 5th transaction in the Life Science sector.
  • This is Pharmaron’s 1st transaction in China.

M&A Deal Summary

Date 2025-10-28
Target Biortus
Sector Life Science
Buyer(s) Pharmaron
Deal Type Add-on Acquisition

Target

Biortus

Jiangyin, China
Biortus is a contract research organization that provides integrated drug discovery services from gene synthesis to structure determination. The Company’s capabilities include protein production, biochemical and cellular assays, compound screening, X-ray crystallography, and cryo-electron microscopy. Biortus was founded in 2009 and is headquartered in Wuxi, China.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Pharmaron

Beijing, China

Category Company
Founded 2004
Sector Life Science
Employees22,908
Revenue 12.3B CNY (2024)
DESCRIPTION

Pharmaron is a publicly owned, premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of R&D service capabilities ranging from synthetic and medicinal chemistry, biology, DMPK, pharmacology, safety assessment, radiochemistry and radiolabelled metabolism, clinical pharmacology, clinical analytical sciences, clinical CRO and SMO, to chemical & pharmaceutical development. With over 10,000 employees, and operations in China, the United States, and the United Kingdom, Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan, and China. Pharmaron was founded in 2004 and is based in Beijing, China.


DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 5 of 5
Type: Add-on Acquisition M&A Deals 4 of 4
Country: China M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-09 Absorption Systems

Exton, Pennsylvania, United States

Absorption Systems assists pharmaceutical, biotechnology, and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) barriers in the development of drugs, biologics, and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. Absorption Systems was founded in 1996 and is based in Exton, Pennsylvania.

Buy $138M